Clinical Trials

50 trials registered for Congenital myotonic dystrophy type 1

Study of ATX-01 in Participants With DM1
NCT06300307Phase 1/2ARTHEx Biotech S.L.
Recruiting
The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
NCT06523400Phase 3Lupin Ltd.
Recruiting
The Spanish National Registry for Myotonic Dystrophy Type 1
NCT07385443N/AFundació Institut Germans Trias i Pujol
Recruiting
The United Kingdom National Registry for Myotonic Dystrophy
NCT04003363N/ANewcastle University
Recruiting
Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy
NCT02269865N/AStanford University
Unknown
Home-based Training and Supplementation in DM1 Patients
NCT05848830Phase 3McMaster University
Unknown
Observational Study of Digital Biomarkers of Myotonia and Gait in Adults and Children With Myotonic Dystrophy
NCT06089018N/AStanford University
Unknown
The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies
NCT00674843Phase 1GAAD Medical Research Institute Inc.
Unknown
Virtual Reality-training in Theory of Mind in the Childhood Form of Myotonic Dystrophy Type 1
NCT05916677N/AInstitut de Myologie, France
Unknown
Evaluation of Cognitive Functions in 20 Patients With Type 1 Myotonic Dystrophy With Virtual Reality Approach
NCT06270186N/ACentre Hospitalier Universitaire de Nice
Withdrawn